Azelaic Acid Encyclopedia — Scientific Background

What Is Azelaic Acid?

Azelaic acid (CAS 123-99-9), also known as nonanedioic acid or 1,7-heptanedicarboxylic acid, is a saturated dicarboxylic acid with the molecular formula C₉H₁₆O₄ and a molecular weight of 188.22 g/mol. It is chemically characterized as HOOC(CH₂)₇COOH. Azelaic acid occurs as a white to slightly yellowish crystalline powder or needles and is practically insoluble in cold water (2.4 g/L at 20°C), but soluble in hot water, ethanol, and organic solvents. It is a naturally occurring compound produced by the ozonolysis of oleic acid and is also found in wheat, barley, and rye.

Physiological Functions of Azelaic Acid

Azelaic acid exhibits a broad spectrum of dermatological activities:

• Keratolytic and Comedolytic — Azelaic acid exerts its keratolytic and comedolytic effects by reducing the thickness of the stratum corneum and keratohyalin granules by reducing the amount and distribution of filaggrin in epidermal layers. This helps unclog pores and prevent comedone formation.

• Antimicrobial Activity — Azelaic acid has demonstrated antibacterial activity against Staphylococcus aureus, Enterococcus faecalis, and Cutibacterium acnes (formerly Propionibacterium acnes), the bacterium implicated in acne pathogenesis.

• Anti-Inflammatory Activity — Azelaic acid possesses a direct anti-inflammatory effect due to its scavenger activity of free oxygen radicals. It modulates the inflammatory response in normal human keratinocytes through PPARγ activation and suppresses UVB-induced expression of IL-1β, IL-6, and TNF-α mRNA.

• Melanin Synthesis Inhibition — Azelaic acid inhibits tyrosinase activity and melanin synthesis, making it effective for hyperpigmentation disorders including melasma and post-inflammatory hyperpigmentation.

• Wound Healing Support — Azelaic acid promotes wound healing through enhanced fibroblast proliferation and extracellular matrix synthesis.

Mechanisms of Action

Keratolytic and Comedolytic Mechanisms

Azelaic acid reduces the thickness of the stratum corneum and the amount and distribution of filaggrin in epidermal layers. This keratolytic effect promotes desquamation and unclogs pores, reducing comedone formation. The comedolytic effect is particularly valuable for acne management, where follicular hyperkeratinization is a key pathogenic factor.

Anti-Inflammatory and Antioxidant Mechanisms

Azelaic acid exerts its anti-inflammatory effects through multiple mechanisms: direct scavenging of free oxygen radicals, activation of peroxisome proliferator-activated receptor γ (PPARγ), suppression of UVB-induced nuclear factor kB p65 subunit nuclear translocation, and inhibition of p38 mitogen and stress-activated protein kinase phosphorylation. These mechanisms collectively reduce inflammatory cytokine production and modulate the inflammatory response in keratinocytes.

Antimicrobial Mechanisms

Azelaic acid exhibits bacteriostatic and bactericidal activity against a range of microorganisms, including Cutibacterium acnes, Staphylococcus aureus, and Enterococcus faecalis. The antimicrobial activity is thought to involve inhibition of bacterial protein synthesis and disruption of microbial cell membranes.

Melanin Synthesis Inhibition

Azelaic acid inhibits tyrosinase, the rate-limiting enzyme in melanin synthesis, and also inhibits mitochondrial oxidoreductase activity in hyperactive melanocytes. This dual mechanism reduces melanin production and is the basis for its use in hyperpigmentation disorders.

The Bioavailability Challenge

Despite its established dermatological efficacy, conventional azelaic acid presents significant formulation and bioavailability challenges. The compound has limited aqueous solubility (2.4 g/L at 20°C) and inadequate penetration across the stratum corneum, which might be related to different possible side effects such as itching and burning. Azelaic acid also has poor absorption through the skin, thus requiring repeated and prolonged application in conventional formulations.

These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. Liposomal azelaic acid formulations prepared by the lipid film hydration method achieved 80.42% encapsulation efficiency with good stability, and exhibited better antibacterial activity, accelerating wound healing effect, and protective effect against oxidative DNA damage compared to free azelaic acid solution.

Liposomal Azelaic Acid

Liposomal encapsulation of azelaic acid provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the azelaic acid molecule, forming a protective shell that enhances stability, skin penetration, and cellular uptake. This delivery system:

• Achieves 80.42% encapsulation efficiency with particle sizes up to 500 nm

• Demonstrates better antibacterial activity compared to free azelaic acid solution

• Shows accelerating wound healing effect in human dermal fibroblasts

• Provides protective effect against hydrogen peroxide-induced DNA damage

• Enhances skin penetration and bioavailability for improved clinical efficacy

Clinical Evidence

FDA-Approved Indications

Azelaic acid is an FDA-approved active ingredient for topical treatment of acne (20% cream, Azelex, approved 1995) and rosacea (15% gel/foam, Finacea). Clinical trials have demonstrated significant efficacy in reducing inflammatory and non-inflammatory acne lesions and in improving rosacea symptoms.

Antibacterial Activity — In Vitro Study

All liposomal formulations of azelaic acid exhibited a better antibacterial effect compared to free azelaic acid solution against Staphylococcus aureus and Enterococcus faecalis. The optimum formulation in terms of both antimicrobial and wound healing effect was ALAipo20% (liposomes with 20% azelaic acid included).

Wound Healing and DNA Protection

Cytotoxicity assays and an in vitro "scratch" test performed with normal human dermal fibroblasts revealed an accelerating healing effect, while a comet assay evidenced the protective effect of azelaic acid liposomal formulations against hydrogen peroxide-induced DNA damage in fibroblasts.

Hyperpigmentation Disorders

Clinical studies have demonstrated the efficacy of azelaic acid in treating melasma, post-inflammatory hyperpigmentation, and other hyperpigmentation disorders through inhibition of tyrosinase activity and melanin synthesis.

Safety and Regulatory

Azelaic acid has a well-established safety profile when used appropriately. The most common side effects are local skin reactions including itching, burning, stinging, erythema, and dryness at the application site, which are typically mild and transient.

Regulatory Status:

• United States — Azelaic acid is an FDA-approved active ingredient for topical treatment of acne (20% cream, Azelex, NDA 020428, approved 1995) and rosacea (15% gel/foam, Finacea). It is regulated as a prescription drug for these indications.

• European Union — Azelaic acid is authorized as a pharmaceutical active ingredient in EU member states. Skinoren (15% gel/20% cream) is approved for acne and rosacea.

• Global Standards — Azelaic acid is monographed in the European Pharmacopoeia and other pharmacopoeias.

Precautions: Individuals with known hypersensitivity to azelaic acid or related compounds should avoid use. Pregnant or lactating women and children should consult a healthcare professional before use. Azelaic acid may interact with certain medications; consult a healthcare professional if taking prescription drugs.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

99$/KG

89$/KG